Chemoinformaics analysis of BUTYRALDEHYDE
Molecular Weight | 72.107 | nRot | 2 |
Heavy Atom Molecular Weight | 64.043 | nRig | 1 |
Exact Molecular Weight | 72.0575 | nRing | 0 |
Solubility: LogS | -0.032 | nHRing | 0 |
Solubility: LogP | 0.615 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 13 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 5 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 12.8163 |
nHD | 0 | BPOL | 8.89366 |
QED | 0.444 |
Synth | 2.735 |
Natural Product Likeliness | 1.653 |
NR-PPAR-gamma | 0.017 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.013 |
HIA | 0.004 |
CACO-2 | -4.228 |
MDCK | 0.000031 |
BBB | 0.949 |
PPB | 0.322086 |
VDSS | 1.077 |
FU | 0.802908 |
CYP1A2-inh | 0.346 |
CYP1A2-sub | 0.707 |
CYP2c19-inh | 0.041 |
CYP2c19-sub | 0.735 |
CYP2c9-inh | 0.009 |
CYP2c9-sub | 0.567 |
CYP2d6-inh | 0.012 |
CYP2d6-sub | 0.543 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.182 |
CL | 8.544 |
T12 | 0.773 |
hERG | 0.076 |
Ames | 0.696 |
ROA | 0.2 |
SkinSen | 0.95 |
Carcinogencity | 0.067 |
EI | 0.994 |
Respiratory | 0.962 |
NR-Aromatase | 0.014 |
Antiviral | No |
Prediction | 0.953861 |